Lyon Cedex 03

• A Phase IIIb, Single Arm, Open-label, Multicentre Study of Durvalumab in Combination with Chemotherapy for the First Line Treatment for Pati … Not authorised
  2022-502043-35-00 5 Advanced Biliary Tract Cancers
• PROSTABACT : Relevance of the treatment with antibiotics before endoscopic surgery of lower urinary symptoms related to prostate hypertrophy … Not authorised
  2023-510191-31-00 5 Benign Prostate Hyperplasia
• Evaluate the efficacy of 12-month neoadjuvant chemotherapy in terms of disease-free survival in patients with localized digestive neuroendoc … Not authorised
  2024-515603-19-00 4 Localized digestive Neuroendocrine Carcinomas
• PRODIGE 113 (FFCD 2314) – REWENEC – 01 STUDY Randomized trial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI with a hybrid synthetic co … Not authorised
  2024-519922-19-00 4 Neuroendocrine carcinoma of gastro-enteropancreatic or unknown origin
• Impact of low dose epinephrine in the management of out-of-hospital cardiac arrest on neurological outcome: A multicenter randomized and do … Pending
  2023-505349-26-00 5 Out-of-hospital cardiac arrest.
• SYMBOL CLINICAL : Treatment of severe ocular chemical burns by subconjunctival injection of allogeneic mesenchymal stem cells: a multicentre … Pending
  2023-509713-37-00 4 Patient with severe eye chemical burns
• Evaluation of a therapeutic de-eScalation strategy based on therapeutic drug MOnitOring in chronic non-infectious uveitis Treated witH adali … Pending
  2023-509733-39-00 6 noninfectious uveitis
• A multicentre, double-blind, randomized controlled trial of inhaled amikacin versus placebo in critically ill patients with ventilator-assoc … Pending
  2023-510075-63-00 5 Patients with ventilator-associated tracheobronchitis
• New therapeutic approach to Toxic Epidermal Necrolysis (TEN) using anti-CD38+ antibodies in the active phase of the disease – Phase I/II stu … Pending
  2024-512164-63-00 9 Toxic Epidermal Necrolysis
• SERORL Effect of aspirin and folic acid for sudden sensorineural hearing loss Pending
  2024-513710-35-00 5 Patients presenting to ENT emergencies with a unilateral sudden sensor
• Randomized double blind controlled trial comparing the safety and efficacy of apremilast versus placebo in severe forms of recurrent aphthou … Pending
  2024-514659-13-00 5 Patients with severe forms of Recurrent Aphthous Stomatitis (RAS)
• BOOSTERS - BiOlogics in FOlliculitis decalvanS : an adaptaTivE tRial reSearch Pending
  2024-514848-88-00 4 Folliculitis decalvans
• Evaluate the efficacy of 12-month neoadjuvant chemotherapy in terms of disease-free survival in patients with localized digestive neuroendoc … Pending
  2024-515603-19-01 4 Localized digestive Neuroendocrine Carcinomas
• The value of post-operative antibiotic therapy after laparoscopic appendectomy for complicated acute appendicitis (other than for generalize … Pending
  2024-515834-34-00 5 complicated acute appendicitis
• MAV-RAPA: Prospective evaluation of the efficacy of sirolimus (Rapamune) in the treatment of superficial arteriovenous malformations. Pending
  2024-516001-23-00 4 superficial arteriovenous malformations
• Severe Erythema Multiforme - CORTICO Pending
  2024-516018-39-00 5 Erythema multiforme (EM) in its severe form managed at the hospital
• BICCS - Beta-lactam Intermittent versus Continuous infusion and Combination antibiotic therapy in Sepsis Pending
  2024-516849-39-01 5 antibiotic therapy in Sepsis
• Maintenance With OSE2101 Plus FOLFIRI, or FOLFIRI After FOLFIRINOX-based Induction Therapy in Locally Advanced or Metastatic Pancreatic Duct … Pending
  2024-518139-12-00 4 locally advanced or metastatic Pancreatic ductal adenocarcinoma
• Comparison of Landiolol versus standard of care for prevention of mortality in patients hospitalized for a septic shock with hypercontractli … Pending
  2024-518251-31-00 5 patients hospitalized for a septic shock with hypercontractlity
• FESTIVAL_Fecal transplantation in Hidradenitis suppurativa : a pilot study Pending
  2024-519003-99-00 4 Hidrdenitis suppurative
• A clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have compl … Pending
  2024-519638-22-00 5 IgA nephropathy
• Early optimization of ceftazidine dosing regimen in critical care : FORTOPTIM_1 Pending
  2024-519783-41-00 4 sepsis
• Lenalidomide versus methotrexate in difficult-to-treat cutaneous lupus erythematosus Pending
  2024-520089-70-00 5 Cutaneous lupus erythematosus
• A Phase 2 trial to assess efficacy and safety of zasocitinib in moderate to severe hidradenitis suppurativa Pending
  2025-522831-33-00 4 Hidradenitis Suppurativa

Showing 1–24 of 185 trials